Abstract:Abstract This abstract discusses an unusual rash caused by an atypical infection in a susceptible individual. A 52-year-old patient was referred in 2022 with a 12-month history of a progressive rash on the right leg with tender, inflamed and erythematous lesions. The patient had a background of severe relapsing polychondritis that was diagnosed in 2016. The disease was being managed with prednisolone 30 mg once daily, after previous failure of other immunosuppressive agents including methotrexate, azathioprine and 6 cycles of IV cyclophosphamide. Additionally, the patient was also on co-trimoxazole for Pneumocystis jirovecii pneumonia prophylaxis. On examination, erythematous and violaceous plaques and nodules were noted at the right leg with the lesions clustering and coalescing at the right medial thigh. A few of the lesions appeared infiltrated with pale material. Several warts were noted on the dorsal aspect of the hands, indicating significant immunosuppression. Differential diagnoses considered included the following: a vasculitic process, deposition disorders or an infective process. An urgent biopsy revealed palisaded granulomatous and neutrophilic dermatosis, indicative of an infectious aetiology. The patient was referred to the infectious diseases team. Acid alcohol-fast bacteria culture and whole-genome sequencing revealed a diagnosis of Mycobacteroides chelonae, a nontuberculous mycobacterium. The patient was commenced on 6 months’ treatment with combined doxycycline 100 mg twice daily and clarithromycin 500 mg twice daily. The patient responded well to treatment, with resolution of nodules on treatment completion. This case highlights the need for an increased index of suspicion in patients with a history of significant immunosuppression. Our patient had undergone QuantiFERON Gold (negative) in 2020 prior to IV cyclophosphamide. There is some evidence to suggest that QuantiFERON Gold may have the capacity to identify patients with nontuberculous mycobacteria (Kobashi Y, Mouri K, Yagi S et al. Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis 2009; 13: 1422–6). There is robust guidance on TB infection screening prior to initiating immunosuppression (interferon-γ release assay and chest radiograph) [National Institute for Health and Care Excellence. Scenario: monitoring of DMARDs. Available at https://cks.nice.org.uk/topics/dmards/management/monitoring-of-dmards/ (last accessed 24 March 2024)]. However, there is a relative paucity of guidance related to infection monitoring after commencement of immunosuppression and the need for repeat QuantiFERON testing. Given the increasing use of complex chemotherapy and immunosuppression regimens in standard practice, retaining a high index of suspicion for complex or atypical infection remains important and serves to highlight the need for appropriate investigation. Developing appropriate guidelines to rationalize infection monitoring of patients on long-term immunosuppression could further improve patient care.

Utilisation of the ESMO-MCBS in practice of HTA.

Lichenoid Drug Eruption Secondary to Adalimumab: A Case Report

Drug-induced Erythroderma in Patients with Acquired Immunodeficiency Syndrome.

Cutaneous adverse drug reactions caused by antituberculosis drugs

A Rare Case of Multidrug-Resistant Lupus Vulgaris with a Mixed Pattern of Resistance - A Long Journey to Diagnosis and Treatment

Psoriasiform Lupus Vulgaris: A Diagnostic Challenge

Oral And Cutaneous Lichenoid Reaction Due To Abatacept Treatment For Rheumatoid Arthritis.

Erythema Multiforme-Like Fixed Drug Eruption During Azathioprine and Hydroxychloroquine Treatment for Systemic Lupus Erythematosus Mimicking Rowell Syndrome: A Rare and Challenging Clinical Scenario

An intensely pruritic pebbled presentation

Maculopapular rash with multiple drug hypersensitivity to cotrimoxazole, amikacin, piperacillin/tazobactam, and meropenem in a patient with hairy cell leukemia

[The importance of aluminiun in dialyseencephalopathie (author's transl)].

Two for One: Tuberculid and Leukocytoclastic Vasculitis in an Adolescent

Dynamic helical chirality of an intramolecularly hydrogen-bonded bisoxazoline.

Severe cutaneous adverse reactions due to isoniazid in a HIV positive patient.

[Paradoxical reaction following antituberculosis therapy in immunocompetent patient]

Nodular vasculitis (erythema induratum) associated with systemic minocycline

Annular drug eruptions

BI21 Lues maligna mimicking pyoderma gangrenosum and cutaneous lymphoma

Cutaneous Squamous Cell Carcinoma in Lupus Vulgaris Caused by Drug Resistant Mycobacterium Tuberculosis

[Lupus vulgaris: isolation of Mycobacterium tuberculosis from the affected skin scraping and mucous membranes]

BI35 A 12-month history of a progressive rash on a background of significant long-term immunosuppression